Showing 3891-3900 of 21451 results for "".
- EEG-Guided Dexmedetomidine-Ketamine Improves Lumbar Fusion Recoveryhttps://reachmd.com/news/eeg-guided-dexmedetomidine-ketamine-improves-lumbar-fusion-recovery/2488381/Key Takeaways Older adults undergoing elective lumbar spine fusion had a smaller 24-hour decline in QoR-15 with a dexmedetomidine-ketamine multimodal protocol plus EEG-guided titration than with conventional balanced anesthesia. The multimodal approach was associated
- Cross-Sectional Coaxial Renal Biopsy Improved Adequacyhttps://reachmd.com/news/cross-sectional-coaxial-renal-biopsy-improved-adequacy/2488382/Key Takeaways In this single-center comparison of adult native kidney biopsies, the cross-sectional coaxial approach was associated with the highest specimen adequacy of the 3 ultrasound-guided techniques studied. It also produced the greatest glomerular yield, with
- Hippocampal-Avoidance WBRT Planning Improved with 4A-HGhttps://reachmd.com/news/hippocampal-avoidance-wbrt-planning-improved-with-4a-hg/2488320/Key Takeaways Across HA-WBRT plans generated on Halcyon and Edge, the four-arc hybrid geometry was associated with a better overall balance between whole-brain target coverage and hippocampal sparing than the open-field arc designs. More extensive convergence setting
- Review Integrates Functional and Aesthetic BTX-A Treatment for Facial Paralysishttps://reachmd.com/news/review-integrates-functional-and-aesthetic-btx-a-treatment-for-facial-paralysis/2488325/Botulinum toxin A (BTX-A) may offer dermatologists a way to address the functional, therapeutic, and aesthetic manifestations of facial paralysis within a single treatment framework, a recent review suggested.d BTX-A Targets Multiple Sequelae of Facial Paralysis The authors conduc
- Telehealth Care Improved Chronic Pain Sick Leave in Primary Carehttps://reachmd.com/news/telehealth-care-improved-chronic-pain-sick-leave-in-primary-care/2488312/Key Takeaways Among working-age adults on sick leave for chronic nonmalignant pain recruited from Swedish primary care, remote PCC added to usual care was associated with a significant 6-month advantage on the prespecified composite of self-efficacy and sick leave. D
- Mefatinib Improves PFS vs Gefitinib in EGFR-Mutated NSCLChttps://reachmd.com/news/mefatinib-pfs-gefitinib-egfr-mutated-nsclc/2488259/Key Takeaways In Chinese adults with untreated advanced EGFR-mutated nonsquamous non-small cell lung cancer receiving first-line mefatinib or gefitinib, progression-free survival was longer with mefatinib in the overall trial population. The clearest efficacy differe
- Survival Improvements in Recurrent and Metastatic ESCC Cohorthttps://reachmd.com/news/survival-recurrent-metastatic-escc/2488233/Key Takeaways In recurrent/metastatic ESCC in a real-world cohort, first-line IT+RT+CT was associated with significantly longer PFS than CT+IT. Across first-line and subsequent-line treatment, OS remained higher with IT+RT+CT than with CT+IT after weighting. Progress
- Online Grocery Swap Prompts Improve Diet Quality, Cut Carbonhttps://reachmd.com/news/online-grocery-swap-prompts-improve-diet-quality-cut-carbon/2488217/Key Takeaways A randomized online grocery trial in 1,201 US adults found that climate, health, and combined swap prompts were each associated with more healthful selections than control. Only climate and combined prompts lowered the carbon footprint of selected foods
- Early Nephrology Consultation Didn’t Improve AKI Outcomeshttps://reachmd.com/news/early-nephrology-consultation-didnt-improve-aki-outcomes/2488166/Key Takeaways At a single U.S. center, hospitalized adults without AKI who were flagged as high risk by ESTOP-AKI had no significant between-group differences in serum creatinine rise or major downstream kidney outcomes with early nephrology consultation. During the
- Wrist Mobility Biomarkers Predicted Incident COPD in UK Biobankhttps://reachmd.com/news/wrist-mobility-biomarkers-predicted-incident-copd-in-uk-biobank/2487966/Key Takeaways Among 28,251 older UK Biobank participants, 2.26% developed COPD over a mean 8.5 years of follow-up. Lower running duration, slower maximal walking speed, shorter longest walking bout duration, and a lower proportion of walks longer than 8 seconds were